SGMT Sagimet Biosciences Inc
842
$4.64
$0.26
(5.94%)
| Watchers | 842 |
| 52-Wk Low | $2.13 |
| 52-Wk High | $20.71 |
| Market Cap | $139.79M |
| Volume | 321,679.00 |
| 52-Wk High | $20.71 |
| 52-Wk Low | $2.13 |
Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives $41.50 Average PT from AnalystsTicker Report • about 1 month ago
Sagimet Biosciences Inc. (NASDAQ:SGMT - Get Free Report) has received an average rating of "Buy" from the six analysts that are currently covering the company, MarketBeat Ratings reports. Six...
Share to Feed
Even if it's not a huge purchase, we think it was good to see that David Happel, the CEO, President & Director of...
Sagimet Biosciences (NASDAQ:SGMT Free Report) had its price objective cut by The Goldman Sachs Group from $37.00 to $27.00 in a report issued on Tuesday, Benzinga reports. They currently have...
Leerink Partnrs restated their outperform rating on shares of Sagimet Biosciences (NASDAQ:SGMT Free Report) in a research report released on Monday, Zacks.com reports. Leerink Partnrs also...
Leerink Partnrs reiterated their outperform rating on shares of Sagimet Biosciences (NASDAQ:SGMT Free Report) in a research report report published on Monday morning, Zacks.com reports...
Comparing SGMT's Performance Against Analyst Estimates and Future ProspectsRelated Stocks: SGMT...
SAN MATEO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN...
Equities research analysts at SVB Leerink assumed coverage on shares of Sagimet Biosciences (NASDAQ:SGMT Get Free Report) in a report released on Monday, MarketBeat.com reports. The firm set...
SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...